Actively Recruiting

Phase Not Applicable
Age: 16Years - 65Years
All Genders
NCT07176988

Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes

Led by Emory University · Updated on 2025-10-20

120

Participants Needed

1

Research Sites

186 weeks

Total Duration

On this page

Sponsors

E

Emory University

Lead Sponsor

N

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research study aims to evaluate the effect of treatment delivery method on voice outcomes over 12 months in people with a primary complaint of a voice problem, diagnosed with either non-phonotraumatic vocal hyperfunction, also known as primary muscle tension dysphonia (MTD) or phonotraumatic vocal hyperfunction, also known as benign vocal fold lesions (lesions). The secondary objectives are: * To evaluate acoustic correlates of clear speech and the relationship to vocal acoustic and patient-reported voice outcomes. * To determine the association between overall dysphonia outcomes and adoption of clear speech.

CONDITIONS

Official Title

Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes

Who Can Participate

Age: 16Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Non-smoking
  • Diagnosis of primary muscle tension dysphonia of the hyperadducted type or benign vocal fold lesions
  • No neuro-laryngologic or age-related vocal fold changes such as atrophy
  • No voice therapy or voice surgery in the last year
  • No serious chronic medical conditions affecting voice as reported by the patient
  • Normal hearing confirmed by pure tone audiometry
  • Suitable for behavioral voice intervention as determined by specialists
  • Willing to attend all therapy and follow-up sessions
  • Willing to use a smartphone to record practice
Not Eligible

You will not qualify if you...

  • History of voice therapy or voice surgery in the last year
  • Serious chronic medical conditions affecting voice as reported by the patient
  • Abnormal hearing despite amplification
  • Laryngeal disorders other than primary MTD and benign vocal fold lesions
  • Not suitable for behavioral voice intervention as determined by specialists
  • Unwilling to attend therapy and follow-up sessions
  • Unwilling to use a smartphone to record practice
  • Pregnant women
  • Prisoners
  • Cognitive impairment or impaired decision-making capacity

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Emory Voice Center at Emory University Hospital Midtown

Atlanta, Georgia, United States, 30308

Actively Recruiting

Loading map...

Research Team

A

Amanda Gillespie, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here